Review Article
High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic Inflammation
Table 3
Circulating levels of ANGPTL2 in autoimmune diseases.
| Reference | Patients | Serum ANGPTL2 (ng/ml) | ELISA kit | Conclusion of the study |
| [61] | Dermatomyositis versus controls, Japan | ~3.8 versus 3.0 in controls | IBL, Japan | Keratinocyte-derived ANGPTL2 contributes to DM pathogenesis by inducing chronic inflammation in skin tissue. | [62] | Rheumatoid arthritis versus controls, Japan | ~3.0 versus 3.0 in controls (NS) | IBL, Japan | Synovial fluid-derived ANGPTL2 (not serum) acts as an important rheumatoid inflammatory mediator in RA pathogenesis. |
|
|
DM: dermatomyositis; NS: nonsignificant; RA: rheumatoid arthritis.
|